obtain optically active β-lactams, including the building block of the cholesterol-lowering drug Ezetimibe. An organocatalytic asymmetricallylicamination of Morita–Baylis–Hillman carbonates with aromatic amines in the presence of β-isocupreidine is described. Chiralallylic amines were obtained in almost quantitative yields (90–96%) with moderate enantioselectivity. Recrystallization afforded products